Table 2.
Variables | Overall Survival Univariate Analysis |
Overall Survival Multivariate Analysis |
||||
---|---|---|---|---|---|---|
HR | 95% CI | p-Value | HR | 95% CI | p-Value | |
Age (≥56 vs. <56) | 1.725 | 0.916–3.248 | 0.091 | |||
Gender (male vs. female) | 0.977 | 0.718–1.330 | 0.883 | |||
Cirrhosis (yes vs. no) | 1.146 | 0.614–2.138 | 0.669 | |||
Tumor number (multiple vs. single) | 1.757 | 0.953–3.239 | 0.071 | |||
Tumor size (>5 cm vs. ≤5 cm) | 1.800 | 0.963–3.364 | 0.065 | |||
Vascular invasion | 2.992 | 1.615–5.543 | <0.001 * | 2.347 | 1.216–4.530 | 0.011 * |
Pathology microvascular invasion | 1.311 | 0.681–2.523 | 0.418 | |||
Pathology nerve tract invasion | 2.846 | 1.490–5.437 | 0.002 * | 3.018 | 1.536–5.927 | 0.001 * |
Pathology differentiation degree (Moderate to poor, poor vs. well, well to moderate, moderate) | 1.483 | 0.719–3.056 | 0.286 | |||
AFP (≥25 vs. <25) | 1.236 | 0.521–2.935 | 0.631 | |||
CA19-9 (≥35 vs. <35) | 2.653 | 1.410–4.989 | 0.002 * | 2.071 | 1.030–4.167 | 0.041 * |
CEA (≥5 vs. <5) | 3.384 | 1.818–6.300 | <0.001 * | 1.965 | 0.880–3.746 | 0.107 |
PIVKA-II (≥40 vs. <40) | 0.463 | 0.182–1.180 | 0.107 | |||
History of cholelithiasis | 1.660 | 0.909–3.032 | 0.099 | |||
Hepatitis B | 0.920 | 0.502–1.687 | 0.788 | |||
HALP (≥43.63 vs. <43.63) | 1.258 | 0.662–2.391 | 0.483 | |||
NLR (≥3.73 vs. <3.73) | 0.475 | 0.238–0.946 | 0.034 * | 1.463 | 0.691–3.098 | 0.320 |
PLR (≥76.51 vs. <76.51) | 0.217 | 0.030–1.580 | 0.132 |
Notes: * p < 0.05.